Raja R. Seethala

29.3k total citations · 5 hit papers
252 papers, 12.1k citations indexed

About

Raja R. Seethala is a scholar working on Surgery, Oncology and Oral Surgery. According to data from OpenAlex, Raja R. Seethala has authored 252 papers receiving a total of 12.1k indexed citations (citations by other indexed papers that have themselves been cited), including 132 papers in Surgery, 110 papers in Oncology and 66 papers in Oral Surgery. Recurrent topics in Raja R. Seethala's work include Salivary Gland Tumors Diagnosis and Treatment (92 papers), Oral and Maxillofacial Pathology (66 papers) and Ear and Head Tumors (61 papers). Raja R. Seethala is often cited by papers focused on Salivary Gland Tumors Diagnosis and Treatment (92 papers), Oral and Maxillofacial Pathology (66 papers) and Ear and Head Tumors (61 papers). Raja R. Seethala collaborates with scholars based in United States, Canada and United Kingdom. Raja R. Seethala's co-authors include Simion I. Chiosea, Robert L. Ferris, Marina N. Nikiforova, Yuri E. Nikiforov, Eleanor Barnes, Jennifer L. Hunt, Sally E. Carty, Linwah Yip, N. Paul Ohori and Sanja Đačić and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Raja R. Seethala

237 papers receiving 11.9k citations

Hit Papers

Impact of Mutational Test... 2011 2026 2016 2021 2011 2017 2014 2015 2021 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Raja R. Seethala United States 58 6.8k 5.3k 2.8k 2.4k 2.0k 252 12.1k
Ronald Ghossein United States 70 5.5k 0.8× 4.9k 0.9× 9.8k 3.5× 645 0.3× 2.1k 1.1× 276 16.0k
Zubair Baloch United States 59 8.0k 1.2× 2.9k 0.5× 10.9k 3.9× 778 0.3× 1.8k 0.9× 322 15.7k
S. Pilotti Italy 54 1.6k 0.2× 4.0k 0.8× 1.1k 0.4× 457 0.2× 1.5k 0.8× 175 9.2k
Abbas Agaimy Germany 56 5.1k 0.7× 4.1k 0.8× 173 0.1× 1.1k 0.4× 2.5k 1.3× 611 12.8k
Primož Strojan Slovenia 49 3.1k 0.5× 2.5k 0.5× 319 0.1× 452 0.2× 385 0.2× 244 7.9k
Bayardo Perez‐Ordoñez Canada 51 4.5k 0.7× 4.0k 0.8× 83 0.0× 1.3k 0.5× 1.3k 0.7× 206 9.6k
Paola Collini Italy 55 1.8k 0.3× 4.9k 0.9× 1.7k 0.6× 323 0.1× 1.8k 0.9× 285 11.5k
Renata Ferrarotto United States 33 1.6k 0.2× 2.7k 0.5× 873 0.3× 271 0.1× 530 0.3× 210 4.7k
César A. Moran United States 61 4.1k 0.6× 3.7k 0.7× 1.5k 0.5× 275 0.1× 1.2k 0.6× 404 12.4k
Chan Kwon Jung South Korea 42 2.2k 0.3× 1.4k 0.3× 3.5k 1.3× 133 0.1× 677 0.3× 306 7.0k

Countries citing papers authored by Raja R. Seethala

Since Specialization
Citations

This map shows the geographic impact of Raja R. Seethala's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raja R. Seethala with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raja R. Seethala more than expected).

Fields of papers citing papers by Raja R. Seethala

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Raja R. Seethala. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raja R. Seethala. The network helps show where Raja R. Seethala may publish in the future.

Co-authorship network of co-authors of Raja R. Seethala

This figure shows the co-authorship network connecting the top 25 collaborators of Raja R. Seethala. A scholar is included among the top collaborators of Raja R. Seethala based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Raja R. Seethala. Raja R. Seethala is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zandberg, Dan P., Lazar Vujanović, David A. Clump, et al.. (2025). Randomized Phase II Study of Concurrent Versus Sequential Pembrolizumab in Combination With Chemoradiation in Locally Advanced Head and Neck Cancer. Journal of Clinical Oncology. 43(23). 2572–2582.
2.
Deutsch, Julie S., Tricia R. Cottrell, Krista Y. Chen, et al.. (2024). Pan-tumor harmonization of pathologic response assessment for standardized data collection in neoadjuvant IO trials (PATHdata): Final analysis of a multi-institutional reproducibility study.. Journal of Clinical Oncology. 42(16_suppl). 2515–2515.
3.
Tjendra, Youley, Jaylou M. Velez Torres, Carmen Gomez‐Fernandez, et al.. (2024). Parsing the thyroid cytopathology suspicious for malignancy diagnosis through molecular‐derived risk of malignancy and other related parameters: Insights into nodule characteristics and practice patterns. Cancer Cytopathology. 133(1). e22904–e22904. 1 indexed citations
4.
Shah, Akeesha A. & Raja R. Seethala. (2021). Squamoglandular Variant of Acinic Cell Carcinoma: A Case Report of a Novel Variant. Head and Neck Pathology. 16(3). 870–875. 5 indexed citations
5.
Hornick, Jason L., Rhonda K. Yantiss, Laura W. Lamps, et al.. (2018). USCAP 2018 Abstracts: Genitourinary Pathology (894–1126). Modern Pathology. 31(S2). 323a–403. 3 indexed citations
6.
Vitale‐Cross, Lynn, Daniel Martı́n, Abraham Schneider, et al.. (2015). Prevention of Tumor Growth Driven by PIK3CA and HPV Oncogenes by Targeting mTOR Signaling with Metformin in Oral Squamous Carcinomas Expressing OCT3. Cancer Prevention Research. 8(3). 197–207. 48 indexed citations
7.
Concha‐Benavente, Fernando, Raghvendra M. Srivastava, Sumita Trivedi, et al.. (2015). Identification of the Cell-Intrinsic and -Extrinsic Pathways Downstream of EGFR and IFNγ That Induce PD-L1 Expression in Head and Neck Cancer. Cancer Research. 76(5). 1031–1043. 253 indexed citations
8.
Srivastava, Raghvendra M., Sumita Trivedi, Fernando Concha‐Benavente, et al.. (2015). STAT1-Induced HLA Class I Upregulation Enhances Immunogenicity and Clinical Response to Anti-EGFR mAb Cetuximab Therapy in HNC Patients. Cancer Immunology Research. 3(8). 936–945. 64 indexed citations
9.
McCoy, Kelly L., Raja R. Seethala, Michaele J. Armstrong, et al.. (2015). The clinical importance of parathyroid atypia: Is long-term surveillance necessary?. Surgery. 158(4). 929–936. 29 indexed citations
10.
Nikiforov, Yuri E., Sally E. Carty, Simion I. Chiosea, et al.. (2015). Impact of the Multi-Gene ThyroSeq Next-Generation Sequencing Assay on Cancer Diagnosis in Thyroid Nodules with Atypia of Undetermined Significance/Follicular Lesion of Undetermined Significance Cytology. Thyroid. 25(11). 1217–1223. 292 indexed citations breakdown →
11.
Egloff, Ann Marie, Ju-Whei Lee, Corey J. Langer, et al.. (2014). Phase II Study of Cetuximab in Combination with Cisplatin and Radiation in Unresectable, Locally Advanced Head and Neck Squamous Cell Carcinoma: Eastern Cooperative Oncology Group Trial E3303. Clinical Cancer Research. 20(19). 5041–5051. 26 indexed citations
12.
Leibowitz, Michael S., Rahul Srivastava, Pedro A. Andrade Filho, et al.. (2013). SHP2 Is Overexpressed and Inhibits pSTAT1-Mediated APM Component Expression, T-cell Attracting Chemokine Secretion, and CTL Recognition in Head and Neck Cancer Cells. Clinical Cancer Research. 19(4). 798–808. 63 indexed citations
13.
Wheeler, Sarah, Doris R. Siwak, Raymond L. Chai, et al.. (2012). Tumor Epidermal Growth Factor Receptor and EGFR PY1068 Are Independent Prognostic Indicators for Head and Neck Squamous Cell Carcinoma. Clinical Cancer Research. 18(8). 2278–2289. 63 indexed citations
14.
Wheeler, Sarah, et al.. (2012). Lyn Kinase Mediates Cell Motility and Tumor Growth in EGFRvIII-Expressing Head and Neck Cancer. Clinical Cancer Research. 18(10). 2850–2860. 29 indexed citations
15.
Bhola, Neil E., Sufi M. Thomas, Maria L. Freilino, et al.. (2011). Targeting GPCR-Mediated p70S6K Activity May Improve Head and Neck Cancer Response to Cetuximab. Clinical Cancer Research. 17(15). 4996–5004. 25 indexed citations
16.
Vaezi, Alec, Shama Buch, William E. Gooding, et al.. (2011). XPF Expression Correlates with Clinical Outcome in Squamous Cell Carcinoma of the Head and Neck. Clinical Cancer Research. 17(16). 5513–5522. 42 indexed citations
17.
Ferris, Robert L., Liqiang Xi, Raja R. Seethala, et al.. (2011). Intraoperative qRT-PCR for Detection of Lymph Node Metastasis in Head and Neck Cancer. Clinical Cancer Research. 17(7). 1858–1866. 48 indexed citations
18.
Knowles, Lynn M., Laura P. Stabile, Ann Marie Egloff, et al.. (2009). HGF and c-Met Participate in Paracrine Tumorigenic Pathways in Head and Neck Squamous Cell Cancer. Clinical Cancer Research. 15(11). 3740–3750. 175 indexed citations
19.
Lai, Stephen Y., Priya Koppikar, Sufi M. Thomas, et al.. (2009). Intratumoral Epidermal Growth Factor Receptor Antisense DNA Therapy in Head and Neck Cancer: First Human Application and Potential Antitumor Mechanisms. Journal of Clinical Oncology. 27(8). 1235–1242. 46 indexed citations
20.
Zhang, Weiping, Neil E. Bhola, Shailaja Kalyankrishna, et al.. (2008). Kinin B2 Receptor Mediates Induction of Cyclooxygenase-2 and Is Overexpressed in Head and Neck Squamous Cell Carcinomas. Molecular Cancer Research. 6(12). 1946–1956. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026